| |
| |
|
| Insider
Information: |
Oronsky Arnold L |
| Relationship: |
Director, 10% Owner |
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
377,534 |
|
|
Indirect Shares
|
8,714,289 |
|
|
| Direct
Value |
$4,204,367 |
|
|
|
Indirect Value
|
$29,074,214 |
|
|
| Total
Shares |
9,091,823 |
|
|
| Total
Value |
$33,278,580 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dynavax Technologies Corp |
DVAX |
Director |
2013-10-30 |
375,055 |
2011-08-02 |
0 |
Premium* |
|
|
Anesiva Inc |
ANSVQ |
Director, 10% Owner |
2005-12-16 |
0 |
2007-12-18 |
47,263 |
Premium* |
|
|
Epocrates Inc |
EPOC |
Former 10% Owner |
2011-02-07 |
0 |
2011-02-07 |
87,087 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
Director |
2018-08-07 |
2,479 |
2017-06-01 |
1,338 |
Premium* |
|
|
Macrogenics Inc |
MGNX |
Director |
2013-10-16 |
0 |
2014-02-18 |
1,708,716 |
Premium* |
|
|
Applied Genetic Technologies Corp |
AGTC |
Director |
2014-04-01 |
0 |
2017-04-24 |
11,208 |
Premium* |
|
|
Kalvista Pharmaceuticals Inc |
KALV |
Director |
|
0 |
2018-09-10 |
388,766 |
Premium* |
|
|
Pmv Pharmaceuticals, Inc. |
PMVP |
Director, 10% Owner |
2020-09-25 |
0 |
2020-09-29 |
6,469,911 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PMVP |
Pmv Pharmaceuticals, Inc. |
Director |
– • • |
2020-09-29 |
4/A |
A |
$0.00 |
$0 |
I/I |
6,414,356 |
6,469,911 |
0 |
- |
|
| PMVP |
Pmv Pharmaceuticals, Inc. |
Director |
– • • |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
6,414,356 |
6,469,356 |
0 |
- |
|
| PMVP |
Pmv Pharmaceuticals, Inc. |
Director |
– • • |
2020-09-25 |
4/A |
B |
$18.00 |
$999,990 |
I/I |
55,555 |
55,555 |
2.25 |
- |
|
| PMVP |
Pmv Pharmaceuticals, Inc. |
Director |
– • • |
2020-09-25 |
4 |
B |
$18.00 |
$990,000 |
I/I |
55,000 |
55,000 |
2.25 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Director |
– • – |
2018-09-10 |
4 |
B |
$17.00 |
$1,000,008 |
I/I |
58,824 |
388,766 |
2.1 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2018-08-07 |
4 |
S |
$26.77 |
$267,721 |
D/D |
(10,000) |
2,479 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2018-08-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,000 |
12,479 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
I/I |
335 |
1,338 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • – |
2017-04-24 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,688 |
11,208 |
0 |
- |
|
| KALV |
Kalvista Pharmaceuticals ... |
Director |
– • – |
2016-11-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
329,942 |
|
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2016-03-18 |
4 |
B |
$35.19 |
$4,999,971 |
I/I |
142,085 |
2,013,786 |
2.1 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2015-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,003 |
10,096 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2015-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
1,263 |
9,093 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2015-01-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(606,000) |
0 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2015-01-12 |
4 |
A |
$0.00 |
$0 |
I/I |
6,000 |
6,000 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,371 |
7,830 |
0 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • • |
2014-04-01 |
4 |
B |
$12.00 |
$908,832 |
I/I |
75,736 |
1,452,216 |
2.25 |
- |
|
| AGTC |
Applied Genetic Technolog... |
Director |
– • • |
2014-04-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,376,480 |
1,376,480 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2014-02-18 |
4 |
S |
$36.50 |
$7,300,000 |
I/I |
(200,000) |
1,708,716 |
0 |
- |
|
| DVAX |
Dynavax Technologies Corp |
Director |
– • – |
2013-10-30 |
4 |
B |
$1.08 |
$200,001 |
D/D |
186,047 |
375,055 |
2.39 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2013-10-16 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,448 |
1,908,716 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2013-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
1,906,268 |
1,906,268 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,216 |
5,459 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-08-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(600,000) |
2,471,701 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,081 |
4,243 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
